Pentwater Capital Management »

Atrium Therapeutics shares owned by Pentwater Capital Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Pentwater Capital Management from 13F filings

Historical chart of Pentwater Capital Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Pentwater Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Pentwater Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.1M 603k 13.37